Nonstimulant Therapy for ADHD
The results of a multicenter, open-label, dose-titration study of GW320659, a novel norepinephrine and dopamine reuptake inhibitor, are reported from GlaxoSmithKline, Research Triangle Park, NC.
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pediatric Neurology Briefs Publishers
2002-08-01
|
| シリーズ: | Pediatric Neurology Briefs |
| 主題: | |
| オンライン･アクセス: | https://www.pediatricneurologybriefs.com/articles/1601 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|